TABLE 3.

Pre- and posttreatment susceptibility results

TreatmentNo. of animalsMIC before treatmentMIC range after treatmentNo. of mice with resistantaS. aureus
Mupirocin19≤0.125 μg/ml≤0.125-8 μg/ml4
128774-49D211 μl/ml1-8 μl/mlb
128774-49E102 μl/ml0.5-4 μl/ml
128774-53A71 μl/ml2-4 μl/ml
  • a Defined as mupirocin MIC of ≥4 μg/ml.

  • b —, susceptibility breakpoints not established.